Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.
about
The Impact of Variables on Particle Size of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers; A Comparative Literature ReviewSurface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and UsesLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functionsPotentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac.Sustained-release genistein from nanostructured lipid carrier suppresses human lens epithelial cell growthPreparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin.Chitosan-based gastroretentive floating drug delivery technology: an updated review.Ocular application of chitosan.Ocular drug delivery system: a reference to natural polymers.Topical delivery of ocular therapeutics: carrier systems and physical methods.Lipid-based nanocarriers for breast cancer treatment - comprehensive review.Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.Application of lipid nanoparticles to ocular drug delivery.Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy.Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies.A critical review about methodologies for the analysis of mucoadhesive properties of drug delivery systems.DNA-loaded chitosan oligosaccharide nanoparticles with enhanced permeability across Calu-3 cells.Nanoparticles for drug delivery to the anterior segment of the eye.Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.Novel lutein loaded lipid nanoparticles on porcine corneal distribution.Chitosan nanoparticles for ocular delivery of cyclosporine A.Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique.Proniosomes derived niosomes: recent advancements in drug delivery and targeting.Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study.Nanoliposome-Encapsulated Brinzolamide-hydropropyl-β-cyclodextrin Inclusion Complex: A Potential Therapeutic Ocular Drug-Delivery System.Modification of solid lipid nanoparticles loaded with nebivolol hydrochloride for improvement of oral bioavailability in treatment of hypertension: polyethylene glycol versus chitosan oligosaccharide lactate.Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.Ocular Drug Delivery.Hydroxypropylmethylcellulose films for the ophthalmic delivery of diclofenac sodium.Polymeric nanocapsules: a potential new therapy for corneal wound healing.Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery.pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluationNovel Caffeic Acid Nanocarrier: Production, Characterization, and Release Modeling
P2860
Q26740190-EA4D921B-DA1A-486A-95C1-44735DBAF140Q28071773-F1DD2A4D-B427-4D22-BBE2-3F2C7CDE15ABQ30366990-AD7B27EF-D5D0-44C3-B630-186DB788D8D2Q34198276-CA69E692-9D72-45C7-95D7-08EA149C9B2CQ35013281-3602B699-F248-463D-957D-4D6BEF9EFCD4Q35727894-0C164489-C271-4204-AD21-E5F857CDCB14Q36951125-720177F9-11C9-42A5-BF5D-2C1AD694D42BQ37134733-FE9711CC-F48D-44E4-8FF5-010297AD7B2EQ37996585-7067A0EF-3EFF-40EE-8EB8-ACDBC6511BDDQ38005199-D480AF3D-D5DE-41E5-91C1-95EE26AA45BAQ38019052-6948C599-7725-42E7-97AC-174FF0B45D7DQ38196446-CE73D898-E2B5-40D3-BBDF-8A6C489C75F8Q38597794-339B5727-05DC-4A91-B0CA-C47F8DD3B253Q38648168-459ACA24-BA8A-440D-AE3C-E4E3B9DE7CA2Q38829320-4B9D997E-A432-42F7-9B76-75FE0C9FFBB3Q38862505-6DA429FE-32B0-4964-9C98-C6D90168FA90Q39103248-27523A64-95F9-43A7-9900-97970662B028Q39153803-912C1075-B987-46FD-91A8-018DC14246EAQ39170252-02AA51EF-CE2D-4939-9C60-47DCE7224BB9Q39182355-5FB5AC55-0BDB-4890-8FD9-FF18C0C70113Q39230212-0F3F94F7-2F40-4003-AC10-8EE1CF3F7377Q40549525-EFE91FDF-C47B-453E-99F2-B0E03FA5E06EQ42738490-9FE8A030-4A65-4731-AF8A-847DF2165911Q44640830-1B5FD0B2-33C4-49DB-B0E3-C9E8570636DFQ44669278-F9D9655C-2A01-4BF7-89E8-0641D56CEB1AQ47355869-43215038-5823-4276-9814-4627814397EBQ47447720-57447F97-D68F-441E-AE53-236594E1EC35Q50295748-277283E3-9AEA-453E-A76C-019A0322E5D5Q50927252-48A644A3-B1D9-4316-81A9-9E898D0ECC4CQ51109699-0214BD78-DFAB-4EF1-8E74-C8D3FE13E270Q51122641-50F3A0B6-6D0A-41FA-BDEE-9E1F9F6F47AEQ51282117-04812303-3364-4603-9E3C-2FAFDC544C0DQ51654129-8626487B-A38F-474B-B560-3DF1209AB853Q52592456-CCE3F2BC-E67A-4579-80E3-867B7D8EB543Q52592946-51E32930-DFFB-43C8-A46B-4287DC435F71Q58698682-78720B10-0BFF-4F3E-8AD7-D958B8707516Q59018330-58BACE36-AC19-467B-8964-A91834D6E36C
P2860
Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Nanostructured lipid carrier ( ...... n ocular drug delivery system.
@ast
Nanostructured lipid carrier ( ...... n ocular drug delivery system.
@en
type
label
Nanostructured lipid carrier ( ...... n ocular drug delivery system.
@ast
Nanostructured lipid carrier ( ...... n ocular drug delivery system.
@en
prefLabel
Nanostructured lipid carrier ( ...... n ocular drug delivery system.
@ast
Nanostructured lipid carrier ( ...... n ocular drug delivery system.
@en
P2093
P1476
Nanostructured lipid carrier ( ...... n ocular drug delivery system.
@en
P2093
Junming Zhao
Qiuhua Luo
Weisan Pan
Xiangrong Zhang
P304
P356
10.1016/J.IJPHARM.2010.10.013
P407
P577
2010-10-15T00:00:00Z